NCT03629925 2023-02-28Sintilimab in Combination With Gemcitabine and Platinum-Based Chemotherapy as First-Line Therapy for Advanced or Metastatic Squamous NSCLCInnovent Biologics (Suzhou) Co. Ltd.Phase 3 Completed357 enrolled 14 charts